AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
On 28 February 2019, Dotz Nano Limited (ASX:DTZ), a company from the Information Technology sector engaged into the Development, manufacture and commercialization of graphene quantum dots, announced its year-end preliminary final report for the period ended 31 December 2018.
The period has been a significant year for Dotz, as the company transitioned from research and development towards commercialization with its end-to-end tracing, marking and verification technology.
The company during the FY2018 adopted a new strategy of go-to-market, where the focus of the company was on sales with end-customers, while moving away from distribution agreements. To efficiently handle this, the company developed a line of sophisticated detectors to complement its unique marker and tracer technology which helped in focusing the market where the technology is the most matured.
Although the technology of Dotz is widely used in various industries, however, the company aimed only three markets where the Dotzâs technology has almost matured. It included anti-counterfeiting, oil and gas and product liability. For this, the company had performed a large-scale trial within its targeted market, to showcase the effectiveness of the Dotz technology on various products, industries as well as the market. The field trial of Dotzâs Fluorensic tracers for fracking in Tulsa Oklahoma (USA), the Anti-counterfeiting trial for the tobacco industry in China as well as the partnership with Monash University got completed during the period.
The strategy used during the period was a success, and it received first customer purchase orders in two of these sectors. Dotz worked on the negotiations in 2018, where the actual orders were received in January 2019. The first purchase order was through its Swiss-based customers in the plastic sector. It also received a purchase order from a global customer from the lubricant sector.
By the end of FY2018 on 31 December 2018, the company made a net loss after tax of US$5,736,672. The company generated revenue from the ordinary activities worth US$15,395 which were down by 86% as compared to the previous corresponding period.
In July 2018, the company completed the capital raising of $2.5 million by issuing 27.78 million shares at A$0.09 per share. The placement was supported by the high net worth investor and the selected group of institutional investors. The purpose of raising funds was to advance its commercialization activities.
Post 31 December 2018, the company again raised A$850,000 through Convertible Notes which got converted to shares and options in February 2019 after receiving the shareholderâs approval in the general meeting held on 8 February 2019.
On 30 January 2019, Dotz obtained A$300,000 through the sale of Validotz in the lubricant sector.
During FY2018, the company appointed a new CEO and the chairman of the company. After the resignation of Mr Faldi Ismail in January, Dr Volker Mirgel was appointed as the new chairman of the board in April 2018.
Outlook:
The company has witnessed a good start in 1H FY2019 where it has secured two purchase orders in plastic and lubricant sectors showing the companyâs ability to penetrate the plastic and lubricant sectors. Now, the company will continue to advance its negotiations in the oil and gas sector through its non-toxic tracers and detectors.
Stock performance
In the last six months, the stock has generated a negative return of 2.38%. However, in the previous three months, the stock has made a return of 6.49%. By the closure of trading session on 28 February 2019, the closing price of the share was A$0.090, up by 9.756% as compared to previous trading dayâs closing price. The company has a market capitalization of A$15.82 million with 192.88 million outstanding shares.
Disclaimer
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.
